Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease

In the present report, we extend previous findings in the 5XFAD mouse model and demonstrate that these mice develop an age-dependent motor phenotype in addition to working memory deficits and reduced anxiety levels as demonstrated in an elevated plus maze task. Employing a variety of N- and C-terminal specific Aβ antibodies, abundant intraneuronal and plaque-associated pathology, including accumulation of pyroglutamate Aβ, was observed as early as the age of 3 months. Using unbiased stereology, we demonstrate that the 5XFAD mice develop a significant selective neuron loss in layer 5 of the cortex, leaving the overall neuron number of the total frontal cortex and hippocampus unaffected. This observation coincides with the accumulation of intraneuronal Aβ peptides only in cortical Layer 5, but not in CA1, despite comparable APP expression levels. The motor phenotype correlates with abundant spinal cord pathology, as demonstrated by abundant intraneuronal Aβ accumulation and extracellular plaque deposition. In addition, comparable to the APP/PS1KI mouse model, 5XFAD mice develop an age-dependent axonopathy likely contributing to the behavioral deficits.

[1]  S. O’Keeffe,et al.  Gait disturbance in Alzheimer's disease: a clinical study. , 1996, Age and ageing.

[2]  H. Steinbusch,et al.  Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. , 2004, The American journal of pathology.

[3]  C. Barrow,et al.  The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. , 1999, Biochemistry.

[4]  P. Greengard,et al.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.

[5]  T. Bayer,et al.  Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. , 2002, Brain pathology.

[6]  G. Perry,et al.  Alzheimer's disease: an intracellular movement disorder? , 2005, Trends in molecular medicine.

[7]  Hans-Ulrich Demuth,et al.  On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). , 2006, Biochemistry.

[8]  T. Bayer,et al.  APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy , 2009, Acta Neuropathologica.

[9]  R. Nitsch,et al.  Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. , 2007, Neurobiology of aging.

[10]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[11]  M. Beal,et al.  β-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients , 2005, Neurobiology of Disease.

[12]  M. Ohno,et al.  Genetic reductions of β‐site amyloid precursor protein‐cleaving enzyme 1 and amyloid‐β ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer’s disease model mice , 2010, The European journal of neuroscience.

[13]  A. Faure,et al.  One‐year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice , 2008, Genes, brain, and behavior.

[14]  M. Emmerling,et al.  Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. , 1997, Biochemical and biophysical research communications.

[15]  Oliver Wirths,et al.  Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[16]  B. Winblad,et al.  P1-480: Amyloid β-peptide levels in laser capture microdissected CA1 pyramidal neurons of Alzheimer's brain , 2008, Alzheimer's & Dementia.

[17]  L. Goldstein,et al.  Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP , 2001, Nature.

[18]  C. Rampon,et al.  Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease , 2011, Neurobiology of Aging.

[19]  T. Bayer,et al.  Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease , 2010, Neurobiology of Aging.

[20]  E. Masliah,et al.  Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa , 1993, Journal of neuropathology and experimental neurology.

[21]  M. Staufenbiel,et al.  Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation , 2002, Brain Research.

[22]  Rie Teraoka,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[23]  R. A. Crowther,et al.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.

[24]  E. Holzbaur,et al.  Axonal transport and neurodegenerative disease. , 2006, Biochimica et biophysica acta.

[25]  S. Qian,et al.  Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination , 2003, Behavioural Brain Research.

[26]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[27]  E. Olsson,et al.  Motor Function in Subjects with Mild Cognitive Impairment and Early Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[28]  L. Thal,et al.  Alzheimer disease without neocortical neurofibrillary tangles , 2004, Neurology.

[29]  T. Bayer,et al.  Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice , 2008, Acta Neuropathologica.

[30]  T. Bayer,et al.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. , 2001, Neuroscience letters.

[31]  P. R. Hof,et al.  Design-based stereology in neuroscience , 2005, Neuroscience.

[32]  Oliver Wirths,et al.  Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice , 2002 .

[33]  M. Ohno,et al.  Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1 , 2006, The European journal of neuroscience.

[34]  Oliver Wirths,et al.  Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease , 2008, Neurobiology of Aging.

[35]  Marie-Claude Potier,et al.  Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.

[36]  P. Greengard,et al.  Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.

[37]  Robert Lalonde,et al.  Exploratory activity and spatial learning in 12-month-old APP 695SWE/co+ PS1/ΔE9 mice with amyloid plaques , 2005, Neuroscience Letters.

[38]  M. Ohno.  Failures to reconsolidate memory in a mouse model of Alzheimer’s disease , 2009, Neurobiology of Learning and Memory.

[39]  T. Bayer,et al.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. , 2004, The American journal of pathology.

[40]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[41]  Samir Kumar-Singh,et al.  Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. , 2008, Neurobiology of aging.

[42]  Mark J West,et al.  Design-based stereological methods for counting neurons. , 2002, Progress in brain research.

[43]  G. Damonte,et al.  Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival. , 2002, Journal of neurochemistry.

[44]  T. Bayer,et al.  Motor impairment in Alzheimer’s disease and transgenic Alzheimer’s disease mouse models , 2008, Genes, brain, and behavior.

[45]  I. Tesseur,et al.  Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. , 2000, The American journal of pathology.

[46]  C. Duyckaerts,et al.  Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[47]  Oliver Wirths,et al.  Age-dependent axonal degeneration in an Alzheimer mouse model , 2007, Neurobiology of Aging.

[48]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[49]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[50]  M. Beal,et al.  Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. , 2005, Neurobiology of disease.

[51]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[52]  A Second Look , 2015 .

[53]  Jacek Szczygielski,et al.  Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease , 2006, Acta Neuropathologica.

[54]  T. Bayer,et al.  Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases , 2009, Journal of Neural Transmission.

[55]  R. Pabst,et al.  Behavioral phenotyping of mice in pharmacological and toxicological research. , 2003, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[56]  G. Damonte,et al.  Pyroglutamate‐modified amyloid β‐peptides – AβN3(pE) – strongly affect cultured neuron and astrocyte survival , 2002 .

[57]  Robert Lalonde,et al.  Transgenic mice expressing the βAPP 695SWE mutation: effects on exploratory activity, anxiety, and motor coordination , 2003, Brain Research.

[58]  T. Bayer,et al.  Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model , 2009, Acta Neuropathologica.

[59]  C. Barrow,et al.  The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ† , 1999 .

[60]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[61]  J. Brandt,et al.  Motor signs predict poor outcomes in Alzheimer disease , 2005, Neurology.

[62]  D. Diamond,et al.  Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. , 2001, DNA and cell biology.

[63]  Heinz H. Bauschke,et al.  Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease , 2005, Genes, brain, and behavior.

[64]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[65]  M. Ohno,et al.  BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice , 2007, Neurobiology of Disease.

[66]  L. Lannfelt,et al.  The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice , 2006, Neurobiology of Aging.

[67]  S. Paik,et al.  Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein , 2004, Journal of neuroscience research.

[68]  M. Ohno,et al.  Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model , 2009, Neurobiology of Disease.

[69]  J. Troncoso,et al.  Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. , 2001, Archives of pathology & laboratory medicine.

[70]  J. Disterhoft,et al.  Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease , 2011, Neurobiology of Aging.

[71]  Annemie Van der Linden,et al.  Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease , 2008, Neurobiology of Aging.

[72]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[73]  M. Ewers,et al.  Associative and motor learning in 12-month-old transgenic APP+PS1 mice , 2006, Neurobiology of Aging.